benazepril hydrochloride and hydrochlorothiazide
- Product NDC
- 0574-0227
- 11-digit product format
- 005740227
- Labeler code
- 0574
- Product ID
- 0574-0227_2484ec1f-5bcc-476a-8bfd-548e37deb4b1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benazepril hydrochloride and hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Padagis US LLC
- Application
- NDA020033
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2019-04-07
- Marketing end
- 0000-00-00
- Substance
- BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0574-0227-01 | benazepril hydrochloride and hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0574-0227 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLET [PADAGIS US LLC] | 6 | Legacy NDC, 1 package rows | 20230524_3e2d3974-38b0-49d0-8020-f74107584724.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0574-0227-01 | 00574022701 | 100 TABLET in 1 BOTTLE (0574-0227-01) | 100 tablet | 2019-04-07 | 0000-00-00 | No | No | Current |